Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Zhejiang University
With
New Horizon Health Technology Co., Ltd
Beijing Mingze Technology Co., Ltd.
The study will be carried out in 8 tier-3A hospitals throughout China. Patients who are at high risk of developing colorectal cancer and willing to conduct colonoscopy examination will be asked to collect stool sample prior to bowl preparation for multitarget FIT-DNA test and commercially available FIT assay. Colonoscopy and histopathologic examination are used as reference.
Age
40–74
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
Willing to provide written consent
Able to provide stool sample
For high risk CRC screening group:
Scheduled for colonoscopy voluntarily or by physician prescription
CRC high risk profile as defined below:
History of FIT positivity
Family history of CRC
Any of two of the following clinical symptoms: chronic constipation/diarrhea, stool with mucous, chronic appendicitis, chronic bilary track diseases, mental stress
For CRC group:
Confirmed CRC patients
No prior treatment with chemotherapy, radiotherapy, and prior to any surgical procedures
